Potent achiral agonists of the growth hormone secretagogue (ghrelin) receptor. Part 2: Lead optimisation.
A series of small molecule orally bioavailable ghrelin receptor agonists have been identified through systematic optimisation of a high throughput screening hit.
Main Authors: | Witherington, J, Abberley, L, Briggs, M, Collis, K, Dean, D, Gaiba, A, King, N, Kraus, H, Shuker, N, Steadman, J, Takle, A, Sanger, G, Wadsworth, G, Butler, S, McKay, F, Muir, A, Winborn, K, Heightman, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Potent achiral agonists of the ghrelin (growth hormone secretagogue) receptor. Part I: Lead identification.
by: Heightman, T, et al.
Published: (2007) -
Neuroprotective actions of ghrelin and growth hormone secretagogues
by: Laura M. Frago, et al.
Published: (2011-09-01) -
Mutational analysis of ghrelin and the growth hormone secretagogue receptor
by: Gueorguiev, M, et al.
Published: (2004) -
Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro.
by: Orkin, R, et al.
Published: (2003) -
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue
by: Kripa Shankar, et al.
Published: (2021-11-01)